Titan Biotech Shares Surge After Stock Split
Shares of biological product manufacturer Titan Biotech experienced a 20% surge, reaching ₹312 on February 20, following a 1:5 stock split. The split, announced in November, aimed to boost liquidity and attract retail investors.
- Stock Split: The 1:5 split increased outstanding shares fivefold, adjusting the price to ₹260 per share.
- Financial Performance: Q3FY26 saw a net profit of ₹8.53 crore, up from ₹4.39 crore year-over-year, with revenue rising 47.6% to ₹56.51 crore.
- Shareholding: Promoters hold 55.8% of the stake, while retail investors hold 44.2%.
